Quantitative Magnetic Resonance Imaging of the Forearm in Myotonic Dystrophy Type 1. [PDF]
Eierle S +9 more
europepmc +1 more source
Lifestyle and dietary measures in Periodic Paralyses. [PDF]
Politano L.
europepmc +1 more source
Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1. [PDF]
González-Martínez I +21 more
europepmc +1 more source
Anaesthesia for Paramyotonia Congenita: A Narrative Review. [PDF]
Chee M +3 more
europepmc +1 more source
Dynamic MR of Muscle Contraction During Electrical Muscle Stimulation: Potential Application to the Evaluation of Neuromuscular Diseases. [PDF]
Santini F +12 more
europepmc +1 more source
Efficacy of Retigabine in Treating Weakness in a Mouse Model of Hypokalemic Periodic Paralysis. [PDF]
Denman K, Rich MM.
europepmc +1 more source
Biophysical and structural insights into the SCN4A E452K variant linked to myotonia and paramyotonia congenita. [PDF]
Plumereau Q +3 more
europepmc +1 more source
Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study. [PDF]
Risi B +15 more
europepmc +1 more source
Role of Otolaryngology in Monitoring the Progression of Myotonic Dystrophy: A Case Report. [PDF]
Pudi V, Shah A.
europepmc +1 more source
Validation of the FVB/N-Tg(HSA* LR)20bCath mice of myotonic dystrophy using swallowing function assessment, histology, and immunofluorescence analysis. [PDF]
Asayama R +5 more
europepmc +1 more source

